Importantly, the ε4 allele of ApoE (ApoE4) dramatically reduces the age of AD onset and is carried by >50% of those afflicted with the disease (Corder et al., 1993), despite an allele frequency of only ~15% in the general population (Utermann et al., 1980). Here, APOE is linked to Alzheimer disease.